Preclinical Safety and Efficacy of Intein-Based Dual-AAV Gene Therapy for Stargardt Disease

被引:0
|
作者
Vila-Perello, Miquel [1 ]
Di Scala, Marianna [1 ]
Aisa, Izarbe [1 ]
Abad, Victor [1 ]
Caelles, Gerard [1 ]
Esteve Rudd, Julian [1 ]
Frutos, Silvia [1 ]
Favre, David [1 ]
机构
[1] SpliceBio, Barcelona, Spain
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
655
引用
收藏
页码:333 / 333
页数:1
相关论文
共 50 条
  • [41] Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry disease
    Jey M. Jeyakumar
    Azadeh Kia
    Lawrence C. S. Tam
    Jenny McIntosh
    Justyna Spiewak
    Kevin Mills
    Wendy Heywood
    Elisa Chisari
    Noemi Castaldo
    Daniël Verhoef
    Paniz Hosseini
    Petya Kalcheva
    Clement Cocita
    Carlos J. Miranda
    Miriam Canavese
    Jaminder Khinder
    Cecilia Rosales
    Derralynn Hughes
    Rose Sheridan
    Romuald Corbau
    Amit Nathwani
    Gene Therapy, 2023, 30 : 487 - 502
  • [42] Dual Adeno-Associated Virus Vector mediated gene therapy for autosomal recessive Stargardt Disease
    Dyka, Frank M.
    Molday, Laurie L.
    Chiodo, Vince A.
    Molday, Robert S.
    Hauswirth, William
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [43] Development of an AAV5-Based Gene Therapy for Fabry Disease
    Liefhebber, Jolanda M. P.
    van der Zon, Tom
    Paerels, Lieke
    Ferraz, Maria J.
    Ottenhoff, Roelof
    Zancanella, Vanessa
    Au, Betty
    Kuo, Chi-Lin
    de Vries, Carlie J. M.
    Evers, Melvin M.
    Konstantinova, Pavlina
    Aerts, Johannes M. F. G.
    Van Deventer, Sander J.
    Liu, Ying Poi
    MOLECULAR THERAPY, 2019, 27 (04) : 442 - 443
  • [44] Development of an AAV5-based gene therapy for Fabry disease
    Liu, Ying Poi
    Liefhebber, Jolanda M. P.
    van der Zon, Tom
    Paerels, Lieke
    Ferraz, Maria J.
    Ottenhoff, Roelof
    Zancanella, Vanessa
    Au, Betty
    Kuo, Chi-Lin
    de Vries, Carlie J. M.
    Evers, Melvin M.
    Konstantinova, Pavlina
    Aerts, Johannes M. F. G.
    Van Deventer, Sander J.
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S99 - S99
  • [45] Development of Novel AAV-Based Gene Therapy for Cardiac Disease
    Whittlesey, K.
    Brooks, G.
    Szymanski, P.
    Beliakoff, G.
    Nye, J.
    Croze, R.
    Schmitt, C.
    Bickta, J.
    Barglow, K.
    Kotterman, M.
    Francis, P.
    Schaffer, D.
    Kirn, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [46] AAV-BASED GENE THERAPY APPROACHES FOR THE TREATMENT OF CANAVAN DISEASE
    Jonquieres, G.
    Mersmann, N.
    Teahan, O.
    Klugmann, C. B.
    Harasta, A. E.
    Lutz, B.
    Housley, G. D.
    Klugmann, M.
    CYTOTHERAPY, 2013, 15 (04) : S12 - S12
  • [47] Efficacy of AAV5-GLA gene therapy in manifest Fabry disease mice
    Liefhebber, Jolanda M. P.
    Brasser, Giso
    Ferraz, Maria J.
    Ottenhoff, Roelof
    Efthymiopoulou, Nikoleta
    Paerels, Lieke
    Pereira, Ines
    Sonea, Andra
    Allart, Leonie
    Schwarz, Lukas K.
    Squeri, Giorgia
    Dobrynin, Greg
    Rodriguez, Rosa Crespo
    Liu, Ying Poi
    Aerts, Johannes M. F. G.
    Montenegro-Miranda, Paula S.
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 81 - 82
  • [48] Preclinical evaluation of AAV9-coSMN1 gene therapy for spinal muscular atrophy: efficacy and safety in mouse models and non-human primates
    Wenhao Ma
    Zhijie Wu
    Tianyi Zhao
    Yan Xia
    Jing Qin
    Xue Tian
    Xin Li
    Jun He
    Yan Zhang
    Lina Zhang
    Li Li
    Zheyue Dong
    Zhichun Feng
    Xiaoyan Dong
    Wang Sheng
    Xiaobing Wu
    Molecular Medicine, 31 (1)
  • [49] Intrathecal AAV9/AP4M1 gene therapy for hereditary spastic paraplegia 50 shows safety and efficacy in preclinical studies
    Chen, Xin
    Dong, Thomas
    Hu, Yuhui
    De Pace, Raffaella
    Mattera, Rafael
    Eberhardt, Kathrin
    Ziegler, Marvin
    Pirovolakis, Terry
    Sahin, Mustafa
    Bonifacino, Juan S.
    Ebrahimi-Fakhari, Darius
    Gray, Steven J.
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (10):
  • [50] Elucidating Complement Activation Mechanisms in AAV Gene Therapy: Development of a Novel ELISA-Based Assay for Enhanced Safety and Efficacy
    Kulak, Klaudia
    Kozma, Viktoria
    Klint, Cecilia
    Nilsson, Camilla
    Tovey, Michael
    Schwenkert, Michael
    Segerstein, Therese
    Rodo, Jordi
    MOLECULAR THERAPY, 2024, 32 (04) : 617 - 618